CLINICAL_TRIALS
ClinicalTrials.gov record update
A Multi-center, Open-label, Single-arm, Phase IV Clinical Trial to Evaluate the Preference Regarding Convenience of Medication, Efficacy and Safety After Switching to SUGAMET®XR Tablet 5/1000mg in Patients With Type 2 Diabetes and Renal Diseases
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04653779
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:54.229469+00:00
- Published At
- 2020-12-11T00:00:00+00:00
- Record Updated At
- 2020-12-11
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diabetes Mellitus, Type 2", "Renal Disease", "Diabetes Mellitus", "Metabolic Disease", "Endocrine System Diseases"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-12-11"- protocolSection.identificationModule.nctId
"NCT04653779"- protocolSection.identificationModule.officialTitle
"A Multi-center, Open-label, Single-arm, Phase IV Clinical Trial to Evaluate the Preference Regarding Convenience of Medication, Efficacy and Safety After Switching to SUGAMET\u00aeXR Tablet 5/1000mg in Patients With Type 2 Diabetes and Renal Diseases"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.